Molecular Docking and Molecular Dynamic Simulation of 1,5-Benzothiazepine Chalcone Derivative Compounds as Potential Inhibitors for Zika Virus Helicase

Authors

  • Neni Frimayanti Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Riau, Indonesia, Indonesia https://orcid.org/0000-0003-2369-6787
  • Musyirna Rahmah Nasution Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Riau, Indonesia, Indonesia
  • Elsa Etavianti Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Riau, Indonesia, Indonesia

DOI:

https://doi.org/10.25077/jrk.v12i1.365

Keywords:

Docking, MD simulation, 1, 5-benzothiazepine, Zika virus, Suramin

Abstract

Zika virus caused of the emerging infections characterized by fever, Guillain-Barré syndrome (GBS) for adults. In the current work, we aimed to study the binding orientation of 1,5-benzothiazepine compounds as new potential agent against Zika virus inhibitor through molecular docking and molecular dynamic simulation. Since, 1-5-Benzothiazepines are particular interest for drug discovery and they also has some biological activities. However, their antiviral activities and in silico studies of the binding to their biological targets have not been extensively investigated. Molecular docking study of 1,5-benzothiazepine chalcone derivatives compounds with protein target 5GJB (PDB ID) and this protein was taken from the crystallographic structure. In this study, twelve 1,5-benzothiazepine chalcone derivative compounds were docked to the protein with the grid box along x, y and z radius of 26.85, 28.17 and 24.43 Å, respectively. Suramin was used as positive control. Thus, it can be used as a reference for design new inhibitors for Zika virus helicase. Based on the docking results, it is observed that compounds MA3 and MA8 are estimated to have activity as inhibitors for Zika virus helicase with binding free energy values of -4.6490 and -4.9291 kcal/mol, respectively. MA3 and MA8 were also stable during the MD simulations with the hydrogen bonding are still maintained before and after MD simulation. Furthermore, both of these compounds can be used an early stage for drug design and drug delivery process.

References

Newman, C., Friedrich, T. C. & O’Connor, D. H., Macaque monkeys in Zika virus research: 1947–present. Curr. Opin. Virol., 25: 34–40 (2017).

Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., et al., Biology of Zika Virus Infection in Human Skin Cells. J. Virol., 89(17): 8880–8896 (2015).

Tan, C. W., Sam, I. C., Chong, W. L., Lee, V. S. & Chan, Y. F., Polysulfonate suramin inhibits Zika virus infection. Antiviral Res., 143(9): 186–194 (2017).

Quanquin, N., Wang, L. & Cheng, G., Potential for treatment and a Zika virus vaccine. Curr. Opin. Pediatr., 29(1): 114–121 (2017).

Vyawahare, D., Ghodke, M. & Nikalje, A. P., Green synthesis and pharmacological screening of novel 1,5-Benzothiazepines as CNS agents. Int. J. Pharm. Pharm. Sci., 2(2): 27–29 (2010).

Bajod, S. S., Synthesis and biological screening of some heterocycles derived from piperonal. Acta Chim. Pharm. Indica, 3(4): 261–267 (2013).

Mor, S., Pahal, P. & Narasimhan, B., Synthesis, characterization, biological evaluation and QSAR studies of 11-p-substituted phenyl-12-phenyl-11a,12-dihydro-11H-indeno[2,1-c][1,5] benzothiazepines as potential antimicrobial agents. Eur. J. Med. Chem., 57: 196–210 (2012).

Gaikwad, S., Suryawanshi, V. S. & Lohar, K., Synthesis and antimicrobial study of novel 2, 3-diydro-4-(naphtho [2, 1-b] furan-2yl)-2-substitued [1, 5] benzothiazepines. J. Chem. Biol. Phys. Sci., 33(22): 936–940 (2013).

Garg, N., Chandra, T., Archana., Jain, A. B. & Kumar, A., Synthesis and evaluation of some new substituted benzothiazepine and benzoxazepine derivatives as anticonvulsant agents. Eur. J. Med. Chem., 45(4): 1529–1535 (2010).

Dong, C. K., Urgaonkar, S., Cortese, J. F., Gamo, F.-J., Garcia-Bustos, J. F., Lafuente, M. J., Patel, V., et al., Identification and Validation of Tetracyclic Benzothiazepines as Plasmodium falciparum Cytochrome bc1 Inhibitors. Chem. Biol., 18(12): 1602–1610 (2011).

Di Santo, R. & Costi, R., 2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase. Farmaco, 60(5): 385–392 (2005).

Ameta, K. L., Rathore, N. S. & Kumar, B., Synthesis and preliminary evaluation of novel 1, 5-benzothiazepine derivatives as anti-lung cancer agents. Int. J. Pharm., 3(2): 328–333 (2013).

Badshah, S. L., Ahmad, N., Ur Rehman, A., Khan, K., Ullah, A., Alsayari, A., Muhsinah, A. Bin., et al., Molecular docking and simulation of Zika virus NS3 helicase. BMC Chem., 13(1): 67 (2019).

Ferreira, L., dos Santos, R., Oliva, G. & Andricopulo, A., Molecular Docking and Structure-Based Drug Design Strategies. Molecules, 20(7): 13384–13421 (2015).

Yaeghoobi, M., Synthesis of chalcone-based six and seven membered heterocyclic compounds and their biological activities against H1N1 virus. University of Malaya, (2012).

Tian, H., Ji, X., Yang, X., Zhang, Z., Lu, Z., Yang, K., Chen, C., et al., Structural basis of Zika virus helicase in recognizing its substrates. Protein Cell, 7(8): 562–570 (2016).

Eryanti, Y., Zamri, A., Frimayanti, N., Teruna, H. Y., Supratmman, U., Herlina, T. & Shiono, Y., Synthesis, Structure-Activity Relationship, Docking and Molecular Dynamic Simulation of Curcumin Analogues Against HL-60 for Anti Cancer Agents (Leukemia). Orient. J. Chem., 33(5): 2164–2172 (2017).

Purnomo, H., Kimia Komputasi Untuk Farmasi dan Ilmu Terkait. Pustaka pelajar, (2013).

Levita, J. & Mustarichie, R., Pemodelan Molekul Dalam Kimia Medisinal. Graha Ilmu, (2012).

Syahputra, G., Ambarsari, L. & Sumaryada, T., Simulasi docking kurkumin enol, bisdemetoksikurkumin dan analognya sebagai inhibitor enzim12-lipoksigenase. J. Biofisika, 10(1): 55–67 (2014).

Meiyanto, E., Docking kurkumin dan senyawa analognya pada reseptor progesteron: studi interaksinya sebagai selective progesterone receptor modulators (SPRMs). Pharmacon J. Farm. Indones., 13(2): 55–60 (2012).

Siswandono. & Soekarjo., Kimia Medisinal Jilid II. Airlangga Univeristy Press, (2006).

Finch, C. A., Industrial water soluble polymers. Royal Society of Chemistry, (1996).

Schaefer, T., Wildman, T. A., Sebastian, R. & McKinnon, D. M., The phenyl group as a hydrogen bond acceptor in 2-phenylphenol derivatives. Substituent comparisons. Can. J. Chem., 62(12): 2692–2696 (1984).

Suhud, F., Siswandono, S. & Budiati, T., Sintesis dan Uji Aktivitas Senyawa 1-Benzil-3-benzoilurea Tersubstitusi Bromo, Kloro, Floro dan Triflorometil pada posisi para sebagai Agen Antiproliferatif. Media Pharm. Indones., 1(3): 154–163 (2017).

Neni, F., Marzieh, Y., Hamid, N., Ihsan, I. & Meysam, A., In silico studies and biological evaluation of chalcone-based 1,5-benzothiazepines as new potential H1N1 neuraminidase inhibitors. J. Appl. Pharm. Sci., 10(10): 086–094 (2020).

Downloads

Published

2021-04-03

How to Cite

Frimayanti, N., Nasution, M. R., & Etavianti, E. (2021). Molecular Docking and Molecular Dynamic Simulation of 1,5-Benzothiazepine Chalcone Derivative Compounds as Potential Inhibitors for Zika Virus Helicase. Jurnal Riset Kimia, 12(1), 44–52. https://doi.org/10.25077/jrk.v12i1.365

Issue

Vol. 12 No. 1 (2021): March

Section

Articles

Citation Check

License

Please find the rights and licenses in Jurnal Riset Kimia (J. Ris. Kim). By submitting the article/manuscript of the article, the author(s) agree with this policy. No specific document sign-off is required.

1. License

The use the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution 4.0 International License. 

2. Author(s)' Warranties

The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

3. User Rights

Under the Creative Commons license, the journal permits users to copy, distribute, and display the material for any purpose. Users will also need to attribute authors and J. Ris. Kim on distributing works in the journal and other media of publications.

4. Rights of Authors

Authors retain all their rights to the published works, such as (but not limited to) the following rights;

  • Copyright and other proprietary rights relating to the article, such as patent rights,
  • The right to use the substance of the article in own future works, including lectures and books,
  • The right to reproduce the article for own purposes,
  • The right to self-archive the article,
  • The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

5. Co-Authorship

If the article was jointly prepared by more than one author, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. J. Ris. Kim will not be held liable for anything that may arise due to the author(s) internal dispute. J. Ris. Kim will only communicate with the corresponding author.